Thursday, May 22, 2025
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home Tags Miti

Tag: miti

biotech stock review
Telehealth

7 Million Telehealth Users This Year, Expected to Drive Revenues to...

Editor / Curator -
Biotech News

Is Telemedicine For Real?

Editor / Curator -
Biotech News

Mass General Brigham to Invest $100 Million in Telehealth and Digital...

Editor / Curator -
Mitesco, Biotech Stock Review
Incubator

True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic...

Editor / Curator -
True Nature, Mitesco, Biotech Stock Review
Incubator

Is True Nature (TNTY) $0.04, Nearing a Breakout?

Editor / Curator -
True Nature, Mitesco, Biotech Stock Review
Accelerator

True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

Editor / Curator -
biogen, biotech stock review
Biotech News

Biotech’s Turning Up…

Editor / Curator -
True Nature, Biotech Stock Review
Accelerator

True Nature | Mitesco (TNTY), Perking Up.

Editor / Curator -
Stand Down.

Stand Down IV: Remember This? Alta Vista Cancels IPO. David Wetherell...

Editor / Curator -
Biotech Stock Review
Incubator

True Nature (TNTY) Mitesco Set to Launch Mitesco PLC Incubator —...

Editor / Curator -
1234Page 3 of 4

Latest article

Cardiol Therapeutics (CRDL) May 2025 Presentation.

2023 Watch List Editor / Curator -
Click here to open. RELATED: Cardiol’s (CRDL) Game-Changing Solution for Heart Inflammation? | David Elsley CEO – Video Interview

Nice Bounce on Alkaline Water (WTER) up 81%.

All News Editor / Curator -
Well now that ain't bad, up 81%! Our outlook on The Alkaline Water Company, our "comeback of the decade" story, is "let's see what...

Zomedica Corp (ZOMDF) $0.05

Uncategorized Editor / Curator -
Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is headquartered in Ann Arbor, Michigan. Initially listed on the TSX Venture...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.